ISO-101, a Wrist-Worn Isometric Counter-Manoeuvre Device, Improves Blood Pressure Recovery in Orthostatic Hypotension

Read the full article

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

ISO-101 is a novel wrist-worn device designed to deliver guided upper-limb isometric counter-manoeuvres via a retractable resistance tether with visual feedback. This proof-of-concept study evaluated feasibility, safety and preliminary efficacy in adults with orthostatic hypotension (OH). In a fixed-sequence, within-participant design, each participant completed three active-stand assessments: unassisted; device activation while supine immediately before standing; and device activation immediately after standing. The primary outcome was the proportion of responders, defined a priori as achieving, with device use versus the unassisted condition, ≥10 mmHg improvement in any one of resting blood pressure, nadir standing blood pressure at 30– 60 s, or reduction in the orthostatic blood-pressure drop (systolic or diastolic). The study was powered to test the responder proportion against a 20% benchmark derived from standard non-pharmacological care. Seventeen participants were enrolled (mean age 72 years; 77% male) and fourteen completed all assessments. Six of fourteen (43%) met the responder definition, exceeding the benchmark (exact binomial p=0.012). When the device was used immediately after standing, responders showed mean (SD) increases of +22.13 (16.29) mmHg systolic and +19.52 (12.47) mmHg diastolic compared with the unassisted stand; pre-stand activation yielded smaller, non-significant changes. No adverse events occurred. Usability was high, with 88% rating the device easy to use and 69% indicating they would use it in daily life. ISO-101 produced clinically meaningful improvements in orthostatic blood pressure in a substantial subset of patients, supporting progression to larger, controlled evaluations.

WHAT IS ALREADY KNOWN

  • Orthostatic hypotension (OH) is common and clinically significant, yet counter-manoeuvres are often poorly implemented in practice.

  • Wearable assistance for standardised counter-manoeuvres has not previously been tested in OH.

WHAT THIS STUDY ADDS

  • In this proof-of-concept study, ISO-101, a guided wrist-worn device, achieved a clinically meaningful and statistically significant responder rate, exceeding that typically observed with standard care.

  • Responders demonstrated marked increases in postural blood pressure, the device was rated as highly usable, and no adverse events were reported.

HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY

  • These findings highlight the potential for wearable-assisted therapy in OH and support the need for further clinical evaluation.

TRIAL REGISTRATION NUMBER

ClinicalTrials.gov : NCT06039410

Article activity feed